Mizuho Securities Upgrades Amedisys (AMED) to Buy; Sell-Off Excessive
- S&P 500 closes higher to secure strongest Q1 since 2019
- UBS sees 5 warnings signals on semiconductor chip stocks
- US consumer sentiment tops estimates in March to hit nearly 3-yr high, UMich says
- Reddit (RDDT) stock continues to slide as short-sellers eye stock
- Estée Lauder (EL) climbs as BofA upgrades to Buy on profit recovery expectations
- AMC Entertainment (AMC) enters into an equity distribution agreement
- Kerrisdale Capital is short Microstrategy (MSTR), long bitcoin
- Discover Financial Services (DFS) Announces CEO Resignation
- Intuitive Machines (LUNR) Files for $300M Share Offering, 160M Share Offering by Selling Stockholders
- AMC Entertainment (AMC) Enters $250M ATM Agreement
Amedisys (AMED) PT Cut to $47 at Mizuho Following Results
November 4, 2016 7:05 AM EDTMizuho Securities analyst Sheryl Skolnick reiterated a Neutral rating and lowered her price target on Amedisys (NASDAQ: AMED) to $47.00 following results.
Skolnick commented, "What the new team has done for AMED in a very short period of time seems close to a miracle... More
Amedisys (AMED) Taps Kindred Healthcare's Gerard as COO
November 4, 2016 6:33 AM EDTAmedisys, Inc. (Nasdaq: AMED) announced that industry leader Christopher Gerard will join the Company as Chief Operating Officer (COO) on January 3, 2017. Daniel McCoy will remain in this role until January 3, 2017.
Gerard brings more than 20 years of home health and hospice experience to the Company. In his new role, Gerard will be responsible for the Amedisys home health, hospice and personal care operations.
Chris has built an impressive track record of strategic, operational and financial accomplishments over the past two decades, said Amedisys President and Chief Executive Officer Paul... More
Amedisys (AMED) Misses Q3 EPS by 8c
November 3, 2016 5:03 PM EDTAmedisys (NASDAQ: AMED) reported Q3 EPS of $0.36, $0.08 worse than the analyst estimate of $0.44. Revenue for the quarter came in at $361.6 million versus the consensus estimate of $361.08 million.
For earnings history and earnings-related data on Amedisys (AMED) click here.
... More